E
Nirvana Life Sciences Inc. NIRV
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

10/31/2024 07/31/2024 04/30/2024 01/31/2024 10/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 40.80K 36.30K 115.50K 96.20K 99.00K
Depreciation & Amortization -- -- 4.50K 9.00K --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 40.80K 36.30K 140.00K 120.20K 114.20K
Operating Income -40.80K -36.30K -140.00K -120.20K -114.20K
Income Before Tax -44.90K -41.00K -256.60K 3.70K -124.30K
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -44.90K -41.00K -256.60K 3.70K -124.30K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 200.00 100.00 200.00 300.00 300.00
Net Income -44.80K -40.90K -256.30K 4.00K -124.00K
EBIT -40.80K -36.30K -140.00K -120.20K -114.20K
EBITDA -37.50K -33.00K -135.50K -117.20K -97.30K
EPS Basic 0.00 0.00 -0.01 0.00 0.00
Normalized Basic EPS 0.00 0.00 0.00 0.00 0.00
EPS Diluted 0.00 0.00 -0.01 0.00 0.00
Normalized Diluted EPS 0.00 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding 48.23M 48.23M 48.34M 48.23M 48.23M
Average Diluted Shares Outstanding 48.23M 48.23M 48.34M 48.23M 48.23M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings